| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Paul K. Audhya is Chief Medical Officer at KALV. From August 2022 to April 2026, the filings on record show 0 open-market purchases and 23 sales. Paul K. Audhya's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.8M at current prices.
Our model assigns Paul K. Audhya a below-average insider score of 44/100, based on 22 past trades. Over a 12-month horizon, 11.8% of those trades were profitable, with an average 12-month return of -38.1%.
The KALV filings lean toward selling, a net 103,890 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 3,125 | $9.82 | $30,700.62 | -3.0% | +23.4% | +58.0% | |
| Nov 26, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,187 | $9.87 | $21,586.13 | -2.2% | +3.8% | +41.3% | |
| Nov 18, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 8,077 | $9.26 | $74,765.56 | -7.9% | +5.2% | +53.4% | |
| Aug 23, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,135 | $12.40 | $26,474.00 | -2.5% | -26.2% | +6.2% | |
| Aug 19, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 7,973 | $12.01 | $95,782.04 | -9.0% | -24.0% | +4.7% | |
| May 20, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 13,175 | $11.76 | $154,997.29 | -15.8% | +3.0% | +3.0% | |
| Feb 20, 2024 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 14,295 | $14.12 | $201,773.93 | -21.3% | -13.9% | -22.4% | |
| Nov 20, 2023 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 7,985 | $8.23 | $65,710.96 | -17.9% | +68.1% | +10.2% | |
| Aug 18, 2023 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 8,020 | $10.73 | $86,044.98 | -23.6% | -29.4% | +11.3% | |
| May 18, 2023 | KALV Kalvista Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,780 | $10.14 | $28,201.43 | -17.6% | +3.7% | +14.6% |